Form 4: Protara Therapeutics VP Controller Sells Shares for Tax
Insider Transaction Report
Protara Therapeutics' VP, Controller, Hannah Fry, disposed of 1,457 common shares to cover tax obligations from a Restricted Stock Unit award.
Summary
- Hannah Fry, VP, Controller of Protara Therapeutics, Inc. (TARA), reported a transaction on January 26, 2026.
- The transaction involved the disposition of 1,457 shares of common stock at a price of $6.67 per share.
- These shares were withheld by the Issuer to satisfy income tax obligations related to the vesting of a Restricted Stock Unit (RSU) Award.
- The RSU Award was originally granted to Ms. Fry on January 24, 2025.
- Following this transaction, Ms. Fry beneficially owns 42,723 shares of Protara Therapeutics common stock.
Sentiment
Score: 5
Explanation: The filing reports a routine administrative transaction (tax withholding) and does not indicate any significant positive or negative sentiment regarding the company's operations or financial health.
Stakeholder Impact
- Minimal impact on shareholders as this is a routine administrative transaction for tax purposes, not a discretionary sale or purchase.
Key Dates
| Date | Description |
|---|---|
| 01/24/2025 | Date of grant for the Restricted Stock Unit Award. |
| 01/26/2026 | Date of transaction where shares were disposed of for tax obligations. |
| 01/27/2026 | Date the Form 4 was signed by the reporting person. |
Keywords
Protara Therapeutics, TARA, Hannah Fry, Insider Transaction, Form 4, Restricted Stock Unit, Tax Withholding, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.